icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 23-26 2021
Back grey_arrow_rt.gif
Cilofexor and Firsocostat Treatment Is Associated With Widespread Changes in the Hepatic Transcriptome in NASH Patients With Advanced Fibrosis
  International Liver Congress, 23-26 June 2021
Yevgeniy Gindin,1 Jen-Chieh (Jay) Chuang,1 Ling Han,1 Catherine Jia,1 Ryan S. Huss,1 Chuhan Chung,1 Robert P. Myers,1 Simone Strasser,2 Vincent Wai-Sun Wong,3 Naim Alkhouri,4 Kris V. Kowdley,5 Mazen Noureddin,6 Rohit Loomba7 1Gilead Sciences, Inc., Foster City, CA, USA; 2Royal Prince Alfred Hospital and The University of Sydney, New South Wales, Australia; 3The Chinese University of Hong Kong, Hong Kong; 4Arizona Liver Health, Chandler, AZ, USA; 5Liver Institute Northwest, Seattle, WA, USA; 6Fatty Liver Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA; 7NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA